Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) CEO George Scorsis responds to the second Hindenburg Research report. Scorsis highlights the self-interest of short sellers as well as the many inaccurate statements in the report in defense of Liberty Health’s practices. Scorsis clears up a misunderstanding about an early stage private placement, in which shares were sold at $0.01, by noting that those shares became tradeable over a year ago and won’t cause future downward pressure on the company’s stock. Liberty Health had a strong quarter, reporting a 45 percent increase in earnings and a patient load growth of 46 percent. Liberty Health will open another 7 stores by February, bringing its total number of dispensaries in Florida to 14 by the end of Q1 2019.
Liberty Health Sciences Inc (CNSX:LHS) CEO on Aphria Inc (TSE:APH) Divestiture Lock-up
Liberty Health Sciences gets approval to implement FlorPass
Liberty Health Sciences CEO: Florida is a Bigger Cannabis Opportunity Than Canada
Liberty Health Sciences CEO George Scorsis, Dmitry Zaytsev & James in Miami - Midas Letter 119